FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:724-727 August 17, 2006 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Fowler, V. G. Related Article by Moran, G. J. PubMed Citation

The decline in the development of new antibiotics, the recognition that partial vancomycin resistance may result in some vancomycin treatment failures among methicillin-resistant Staphylococcus aureus (MRSA) infections, and the emergence of new community-associated MRSA strains that are genetically unrelated to earlier health care–associated MRSA strains have resulted in a reassessment of how best to treat these infections.^1,2,3,4,5 Basic practices such as separation of infected patients from other types of patients, routine cleaning of shared equipment, and appropriate hand hygiene by health care workers are being rediscovered as vital means of controlling the transmission of MRSA.⁶ Numerous community-associated MRSA clones have . . . [Full Text of this Article]

Source Information

From the Department of Infectious Diseases, Austin Health, and the Department of Medicine, University of Melbourne, and the Department of Epidemiology and Preventive Medicine, Monash University — all in Melbourne, Australia.

This article has been cited by other articles:

• Sandberg, A., Hessler, J. H. R., Skov, R. L., Blom, J., Frimodt-Moller, N. (2009). Intracellular Activity of Antibiotics against Staphylococcus aureus in a Mouse Peritonitis Model. Antimicrob. Agents Chemother. 53: 1874-1883 [Abstract] [Full Text]  
• Lloyd, K. M., Schammel, L. M. (2008). Clinical Progression of CA-MRSA Skin and Soft Tissue Infections: A New Look at an Increasingly Prevalent Disease. Arch Dermatol 144: 952-954 [Full Text]  
• Osborne, M. (2007). Update in Critical Care. ANN INTERN MED 147: 412-416 [Full Text]  
• Ruhe, J. J., Menon, A. (2007). Tetracyclines as an Oral Treatment Option for Patients with Community Onset Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 51: 3298-3303 [Abstract] [Full Text]  
• Jones, R. N., Nilius, A. M., Akinlade, B. K., Deshpande, L. M., Notario, G. F. (2007). Molecular Characterization of Staphylococcus aureus Isolates from a 2005 Clinical Trial of Uncomplicated Skin and Skin Structure Infections. Antimicrob. Agents Chemother. 51: 3381-3384 [Abstract] [Full Text]  
• (2006). New Staph Drug Holds Its Own in Serious Infections. JWatch General 2006: 2-2 [Full Text]  
• (2006). MRSA in the ED: Plus Ca Change . . .. JWatch Emergency Med. 2006: 1-1 [Full Text]  
• (2006). Daptomycin for S. aureus Bacteremia and Endocarditis?. Journal Watch Cardiology 2006: 2-2 [Full Text]  
• (2006). Staphylococcal Infections -- From the Surface to the Depths. JWatch Infect. Diseases 2006: 1-1 [Full Text]